Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study

被引：0
|
作者：
Christiane Querfeld
Winnie W. Nelson
Deval Gor
Chris L. Pashos
Quan V. Doan
Marco Turini
James T. Angello
Larisa J. Geskin
机构：
[1] City of Hope and Beckman Research Institute,Department of Dermatology
[2] Helsinn Therapeutics (U.S.),undefined
[3] Inc.,undefined
[4] Genesis Research,undefined
[5] LLC.,undefined
[6] Helsinn Healthcare SA,undefined
[7] Columbia University,undefined
来源：
Dermatology and Therapy | 2022年 / 12卷
关键词：
Chlormethine gel; Mechlorethamine gel; Mycosis fungoides-type cutaneous T-cell lymphoma; MF-CTCL; Registry; Real-world setting; Treatment patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2781 / 2795
页数：14
相关论文
共 30 条
  • [1] Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
    Querfeld, Christiane
    Nelson, Winnie W.
    Gor, Deval
    Pashos, Chris L.
    Doan, Quan, V
    Turini, Marco
    Angello, James T.
    Geskin, Larisa J.
    DERMATOLOGY AND THERAPY, 2022, 12 (12) : 2781 - 2795
  • [2] Maintenance therapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study
    Querfeld, Christiane
    Turini, Marco
    Gor, Deval
    Angello, James T.
    Pashos, Chris
    Kim, Ellen J.
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S45 - S45
  • [3] Concomitant use of steroids or phototherapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study
    Querfeld, Christiane
    Turini, Marco
    Gor, Deval
    Angello, James T.
    Pashos, Chris
    Kim, Ellen J.
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S44 - S45
  • [4] Schedule frequency of chlormethine gel for patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): A real-world evidence study
    Querfeld, Christiane
    Binder, Gary
    Turini, Marco
    Gor, Deval
    Wassel, Christina L.
    Pashos, Chris
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB77 - AB77
  • [5] Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
    Denis, Daphne
    Beneton, Nathalie
    Laribi, Kamel
    Maillard, Herve
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2241 - 2251
  • [6] Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma
    Talpur, Rakhshandra
    Venkatarajan, Sangeetha
    Duvic, Madeleine
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (05) : 591 - 597
  • [7] Use of mechlorethamine gel in patients diagnosed with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): "Real-world'' experience from the Prospective Observational Study (PROVe)
    Geskin, Larissa
    Guitart, Joan
    Kim, Ellen
    Sharma, Gaurav
    Zhao, Carol
    Rengarajan, Badri
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB307 - AB307
  • [8] Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
    Crimp, Caitlin
    Gangal, Ameya
    Tarabadkar, Erica S.
    Shinohara, Michi M.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3271 - 3279
  • [9] Efficacy of chlormethine gel in patients with stage I-IIA mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): re-analysis of a randomized phase 2 study
    Kim, E. J.
    Geskin, L. J.
    Mink, D.
    Williams, M.
    Angello, J.
    Bailey, W.
    Kim, Y.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S30 - S30
  • [10] No detectable systemic absorption of topically applied 0.02% and 0.04% chlormethine (CL) gel in patients with mycosis-fungoides cutaneous T-cell lymphoma (MF-CTCL)
    Querfeld, C.
    Scarisbrick, J.
    Quaglino, P.
    Papadavid, E.
    Romero, P. Ortiz
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S109 - S109
123